CG Asset Management’s Gilead Sciences GILD Stock Holding History

CG Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.26M	Sell	31,550 -755	-2%	-$56.1K	0.84%	42
2016 Q3	$2.56M	Buy	32,305 +700	+2%	+$56.9K	0.96%	37
2016 Q2	$2.64M	Sell	31,605 -49,184	-61%	-$4.36M	1.06%	32
2016 Q1	$7.42M	Sell	80,789 -760	-0.9%	-$68.5K	2.97%	5
2015 Q4	$8.25M	Sell	81,549 -1,585	-2%	-$165K	3.28%	5
2015 Q3	$8.16M	Buy	83,134 +2,030	+3%	+$225K	3.45%	4
2015 Q2	$9.5M	Buy	81,104 +7,685	+10%	+$840K	3.62%	3
2015 Q1	$7.21M	Hold	73,419	–	–	2.8%	4
2014 Q4	$6.92M	Buy	73,419 +1,380	+2%	+$143K	2.73%	5
2014 Q3	$7.67M	Sell	72,039 -1,835	-2%	-$180K	3.16%	3
2014 Q2	$6.13M	Buy	73,874 +4,020	+6%	+$313K	2.59%	4
2014 Q1	$4.95M	Buy	69,854 +3,640	+5%	+$285K	2.23%	8
2013 Q4	$4.97M	Buy	+66,214	New	+$4.61M	2.28%	6

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CG Asset Management's GILD Position: Q4 2016 in Review

CG Asset Management reduced its Gilead Sciences (GILD) stake by 2.3% in Q4 2016, selling an estimated $56.1K and leaving 31,550 shares worth $2.26M. The position accounts for 0.84% of the portfolio, ranked #42.

CG Asset Management first reported a position in GILD in Q4 2013 and has held it in 13 quarters since. The position peaked at $9.5M in Q2 2015. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

CG Asset Management held 31,550 shares of Gilead Sciences worth $2.26M as of Q4 2016.
CG Asset Management sold 755 Gilead Sciences shares in Q4 2016, an estimated $56.1K.
Gilead Sciences made up 0.84% of CG Asset Management's portfolio in Q4 2016, its #42 holding.
CG Asset Management first reported a position in Gilead Sciences in Q4 2013 and has held it in 13 quarters since.
CG Asset Management's Gilead Sciences position peaked at $9.5M in Q2 2015.
1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on CG Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.